Unspecified B-cell lymphoma, in remission is a hematological malignancy characterized by the proliferation of B-lymphocytes. This condition is clinically significant as it indicates a previous diagnosis of B-cell lymphoma that has responded to treatment, necessitating accurate coding for effective documentation, billing, and public health reporting. The ICD-10 Code C85.1A facilitates precise diagnosis and ensures compliance with healthcare regulations.
ICD-10 Code C85.1A represents Unspecified B-cell lymphoma, in remission, indicating that the patient has a history of B-cell lymphoma that is currently not active. This code should be used in clinical documentation and billing when a patient has achieved remission, allowing for appropriate tracking of treatment outcomes and healthcare resource utilization.
Unspecified B-cell lymphoma, in remission, is a type of non-Hodgkin lymphoma that arises from B-cells. The condition can result from genetic mutations or environmental factors and may progress to more severe forms if not monitored. Medical attention is crucial to manage potential relapses and ensure ongoing patient health.
ICD-10 Code C85.1A is utilized in SOAP notes to document the patient's remission status, guiding clinical assessments and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management and accurate billing.
In SOAP notes, ICD-10 Code C85.1A connects subjective reports of patient history and objective clinical findings to a formal diagnosis of remission. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Management of Unspecified B-cell lymphoma, in remission, focuses on monitoring and supportive care to prevent relapse.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C85.1A is essential for accurate billing in hospital, ER, or oncology settings.
| CPT Code | Description |
|---|---|
| 99213 | Established patient office visit, moderate complexity. |
| 85025 | Complete blood count with differential. |
| 36415 | Collection of venous blood by venipuncture. |
Common Questions About Using ICD-10 Code C85.1A for Unspecified B-cell lymphoma, in remission
What does it mean if a patient is in remission?
Being in remission means that the signs and symptoms of the lymphoma are not currently present, indicating a positive response to treatment. However, ongoing monitoring is essential to detect any potential relapse.
How often should follow-up visits occur for patients in remission?
Follow-up visits for patients in remission are typically scheduled every 3 to 6 months, depending on the patient's individual risk factors and treatment history, to monitor for any signs of recurrence.
Can patients with this diagnosis experience symptoms?
Patients in remission may not experience symptoms; however, they should remain vigilant for any new or returning symptoms and report them to their healthcare provider promptly.
Is there a risk of relapse for patients in remission?
Yes, patients in remission are at risk of relapse, which is why regular monitoring and follow-up care are crucial to ensure early detection and management of any recurrence.
Clinical Notes
SOAP notes
DAP notes
AI medical notes